Compare ESRT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESRT | BLFS |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.4M | 923.5M |
| IPO Year | 2012 | 2013 |
| Metric | ESRT | BLFS |
|---|---|---|
| Price | $5.74 | $21.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $6.35 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.2M | 326.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | 0.01 | ★ 0.02 |
| Revenue | ★ $768,270,000.00 | $96,214,000.00 |
| Revenue This Year | $4.26 | $19.73 |
| Revenue Next Year | $1.52 | $17.82 |
| P/E Ratio | $22.66 | ★ N/A |
| Revenue Growth | 0.05 | ★ 16.97 |
| 52 Week Low | $4.87 | $17.86 |
| 52 Week High | $8.76 | $29.57 |
| Indicator | ESRT | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.42 | 56.20 |
| Support Level | $4.87 | $21.35 |
| Resistance Level | $7.04 | $26.14 |
| Average True Range (ATR) | 0.18 | 1.03 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 90.91 | 68.35 |
Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.